Liu KX - Search Results

1

Targeting macrophage Syk enhances responses to immune checkpoint blockade and radiotherapy in high-risk neuroblastoma.

Rohila D, Park IH, Pham TV, Jones R, Tapia E, Liu KX, Tamayo P, Yu A, Sharabi AB, Joshi S. Rohila D, et al. Among authors: liu kx. Front Immunol. 2023 Jun 7;14:1148317. doi: 10.3389/fimmu.2023.1148317. eCollection 2023. Front Immunol. 2023. PMID: 37350973 Free PMC article.

2

Clinical outcomes of radiation therapy for transgender and gender-expansive people with cancer.

Mansur A, Kempf AM, Bitterman DS, Patel CG, Dyer MA, Haas-Kogan DA, Liu KX, Smart AC. Mansur A, et al. Among authors: liu kx. Front Oncol. 2023 Sep 7;13:1135400. doi: 10.3389/fonc.2023.1135400. eCollection 2023. Front Oncol. 2023. PMID: 37746299 Free PMC article.

3

Multi-institutional Characterization of Outcomes for Pediatric and Young Adult Patients With High-Risk Myxopapillary Ependymoma After Radiation Therapy.

Liu KX, Indelicato DJ, Paulino AC, Looi WS, Catalano PJ, Chintagumpala MM, Gallotto SL, Marcus KJ, Haas-Kogan DA, Tarbell NJ, MacDonald SM, Mahajan A, Yock TI. Liu KX, et al. Int J Radiat Oncol Biol Phys. 2023 Dec 1;117(5):1174-1180. doi: 10.1016/j.ijrobp.2023.06.2293. Epub 2023 Jul 10. Int J Radiat Oncol Biol Phys. 2023. PMID: 37437812

4

miR-4516 predicts poor prognosis and functions as a novel oncogene via targeting PTPN14 in human glioblastoma.

Cui T, Bell EH, McElroy J, Becker AP, Gulati PM, Geurts M, Mladkova N, Gray A, Liu K, Yang L, Liu Z, Fleming JL, Haque SJ, Barnholtz-Sloan JS, Ligon KL, Beroukhim R, Robe P, Chakravarti A. Cui T, et al. Oncogene. 2019 Apr;38(16):2923-2936. doi: 10.1038/s41388-018-0601-9. Epub 2018 Dec 17. Oncogene. 2019. PMID: 30559405 Free PMC article.

5

Rectosigmoid Cancer-Rectal Cancer or Sigmoid Cancer?

Hui C, Baclay R, Liu K, Sandhu N, Loo P, von Eyben R, Chen C, Sheth V, Vitzthum L, Chang D, Pollom E. Hui C, et al. Am J Clin Oncol. 2022 Aug 1;45(8):333-337. doi: 10.1097/COC.0000000000000931. Epub 2022 Jul 18. Am J Clin Oncol. 2022. PMID: 35848736 Free PMC article.

6

Cerebellopontine angle ependymoma presenting as isolated hearing loss in an elderly patient: A case report and literature review.

Dibs K, Prasad RN, Madan K, Liu K, Jiang W, Ghose J, Blakaj DM, Palmer JD, Kobalka P, Prevedello DM, Raval RR. Dibs K, et al. Surg Neurol Int. 2021 Nov 23;12:572. doi: 10.25259/SNI_781_2021. eCollection 2021. Surg Neurol Int. 2021. PMID: 34877058 Free PMC article.

7

Intracranial Control With Combination BRAF and MEK Inhibitor Therapy in Patients With Metastatic Melanoma.

Hui C, Wu YF, Liu K, Sandhu N, Blomain E, Binkley MS, Gephart MH, Chang SD, Li GH, Reddy SA, Soltys SG, Pollom E. Hui C, et al. Cureus. 2022 Nov 23;14(11):e31838. doi: 10.7759/cureus.31838. eCollection 2022 Nov. Cureus. 2022. PMID: 36579260 Free PMC article.

8

MicroRNA-575 acts as a novel oncogene via targeting multiple signaling pathways in glioblastoma.

Gray A, Cui T, Bell EH, McElroy J, Sebastian E, Li F, Geurts M, Liu K, Robe P, Haque SJ, Chakravarti A. Gray A, et al. Exp Mol Pathol. 2022 Oct;128:104813. doi: 10.1016/j.yexmp.2022.104813. Epub 2022 Jul 25. Exp Mol Pathol. 2022. PMID: 35901926

9

A Novel miR-146a-POU3F2/SMARCA5 Pathway Regulates Stemness and Therapeutic Response in Glioblastoma.

Cui T, Bell EH, McElroy J, Liu K, Sebastian E, Johnson B, Gulati PM, Becker AP, Gray A, Geurts M, Subedi D, Yang L, Fleming JL, Meng W, Barnholtz-Sloan JS, Venere M, Wang QE, Robe PA, Haque SJ, Chakravarti A. Cui T, et al. Mol Cancer Res. 2021 Jan;19(1):48-60. doi: 10.1158/1541-7786.MCR-20-0353. Epub 2020 Sep 24. Mol Cancer Res. 2021. PMID: 32973101

10

[No title available]

[No authors listed] [No authors listed] PMID: 37785900

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

358 results

Search Page